PL2029122T3 - Transdermalny system terapeutyczny ulegający samozniszczeniu - Google Patents

Transdermalny system terapeutyczny ulegający samozniszczeniu

Info

Publication number
PL2029122T3
PL2029122T3 PL07764544T PL07764544T PL2029122T3 PL 2029122 T3 PL2029122 T3 PL 2029122T3 PL 07764544 T PL07764544 T PL 07764544T PL 07764544 T PL07764544 T PL 07764544T PL 2029122 T3 PL2029122 T3 PL 2029122T3
Authority
PL
Poland
Prior art keywords
autodestructive
therapeutic system
transdermal therapeutic
transdermal
therapeutic
Prior art date
Application number
PL07764544T
Other languages
English (en)
Inventor
Hans-Rainer Hoffmann
Thomas Hille
Original Assignee
Lts Lohmann Therapie Systeme Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lts Lohmann Therapie Systeme Ag filed Critical Lts Lohmann Therapie Systeme Ag
Publication of PL2029122T3 publication Critical patent/PL2029122T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B09—DISPOSAL OF SOLID WASTE; RECLAMATION OF CONTAMINATED SOIL
    • B09B—DISPOSAL OF SOLID WASTE NOT OTHERWISE PROVIDED FOR
    • B09B3/00—Destroying solid waste or transforming solid waste into something useful or harmless
    • B09B3/0075—Disposal of medical waste
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B09—DISPOSAL OF SOLID WASTE; RECLAMATION OF CONTAMINATED SOIL
    • B09B—DISPOSAL OF SOLID WASTE NOT OTHERWISE PROVIDED FOR
    • B09B2101/00—Type of solid waste
    • B09B2101/65—Medical waste
    • B09B2101/68—Transdermal patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Environmental & Geological Engineering (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL07764544T 2006-05-31 2007-05-22 Transdermalny system terapeutyczny ulegający samozniszczeniu PL2029122T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102006025282A DE102006025282A1 (de) 2006-05-31 2006-05-31 Selbstzerstörendes transdermales therapeutisches System
PCT/EP2007/004516 WO2007137732A2 (de) 2006-05-31 2007-05-22 Selbstzerstörendes transdermales therapeutisches system
EP07764544.8A EP2029122B1 (de) 2006-05-31 2007-05-22 Selbstzerstörendes transdermales therapeutisches system

Publications (1)

Publication Number Publication Date
PL2029122T3 true PL2029122T3 (pl) 2015-10-30

Family

ID=38690122

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07764544T PL2029122T3 (pl) 2006-05-31 2007-05-22 Transdermalny system terapeutyczny ulegający samozniszczeniu

Country Status (14)

Country Link
US (1) US8075912B2 (pl)
EP (2) EP2029122B1 (pl)
JP (2) JP5415941B2 (pl)
KR (1) KR101410202B1 (pl)
CN (2) CN101453997A (pl)
AU (1) AU2007267464B2 (pl)
BR (1) BRPI0711858B8 (pl)
CA (1) CA2650833C (pl)
DE (1) DE102006025282A1 (pl)
ES (1) ES2536507T3 (pl)
MX (1) MX2008015276A (pl)
PL (1) PL2029122T3 (pl)
WO (1) WO2007137732A2 (pl)
ZA (1) ZA200809004B (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008016804B4 (de) * 2008-04-02 2012-01-05 Lts Lohmann Therapie-Systeme Ag Selbstzerstörendes transdermales therapeutisches System mit verbesserter Funktionalität und Wirksamkeit sowie seine Verwendung
US9782359B2 (en) 2008-05-05 2017-10-10 Euro-Celtique S.A. Opioid composition for treating skin lesions
DE102009036485B4 (de) * 2009-08-07 2012-10-04 Lts Lohmann Therapie-Systeme Ag Mittel zur zerstörenden Entsorgung von medizinischen Wirkstoffen in transdermalen therapeutischen Systemen
US20180256562A1 (en) * 2015-09-14 2018-09-13 Amneal Pharmaceuticals Llc Transdermal Delivery System
CA3011929A1 (en) * 2016-01-20 2017-07-27 Lts Lohmann Therapie-Systeme Ag Controlling water release from a dimensionally stable aqueous composition
GB201616223D0 (en) * 2016-09-23 2016-11-09 University College Cardiff Consultants Limited Topical treatment patch

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4917676A (en) * 1986-11-20 1990-04-17 Ciba-Geigy Corporation User-activated transdermal therapeutic system
US5236714A (en) 1988-11-01 1993-08-17 Alza Corporation Abusable substance dosage form having reduced abuse potential
US5149538A (en) * 1991-06-14 1992-09-22 Warner-Lambert Company Misuse-resistive transdermal opioid dosage form
EP1424973B1 (en) * 2001-04-23 2010-03-03 Euro-Celtique S.A. Disposal system for transdermal dosage form
PT1397095E (pt) * 2001-05-01 2009-02-17 Euro Celtique Sa Sistemas transdérmicos que contêm opióides resistentes a violação
US7125561B2 (en) 2001-05-22 2006-10-24 Euro-Celtique S.A. Compartmentalized dosage form
DE10250084A1 (de) 2002-10-25 2004-05-06 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
US20040219195A1 (en) * 2003-04-30 2004-11-04 3M Innovative Properties Company Abuse-resistant transdermal dosage form
US7182955B2 (en) 2003-04-30 2007-02-27 3M Innovative Properties Company Abuse-resistant transdermal dosage form
US20050112068A1 (en) 2003-10-28 2005-05-26 Warner Kevin S. Systems and methods for reducing unintended use of active ingredients in dermal delivery devices
US7867511B2 (en) * 2004-01-23 2011-01-11 Travanti Pharma Inc. Abuse potential reduction in abusable substance dosage form
DE102004019916A1 (de) * 2004-04-21 2005-11-17 Grünenthal GmbH Gegen Missbrauch gesichertes wirkstoffhaltiges Pflaster
US20070014839A1 (en) * 2005-07-18 2007-01-18 Stefan Bracht Decomposer film for transdermal patches

Also Published As

Publication number Publication date
KR20090012252A (ko) 2009-02-02
ES2536507T3 (es) 2015-05-26
AU2007267464A1 (en) 2007-12-06
EP2029122B1 (de) 2015-04-22
AU2007267464B2 (en) 2012-07-26
CA2650833C (en) 2014-07-15
WO2007137732A2 (de) 2007-12-06
CN102526002A (zh) 2012-07-04
KR101410202B1 (ko) 2014-06-19
BRPI0711858B1 (pt) 2020-04-22
US8075912B2 (en) 2011-12-13
CN101453997A (zh) 2009-06-10
EP2907510A1 (de) 2015-08-19
JP2014055162A (ja) 2014-03-27
WO2007137732A3 (de) 2008-06-19
ZA200809004B (en) 2009-10-28
JP5415941B2 (ja) 2014-02-12
MX2008015276A (es) 2008-12-12
JP2009538842A (ja) 2009-11-12
DE102006025282A1 (de) 2007-12-20
BRPI0711858A2 (pt) 2011-12-13
BRPI0711858B8 (pt) 2021-05-25
JP5689943B2 (ja) 2015-03-25
CN102526002B (zh) 2014-07-02
EP2029122A2 (de) 2009-03-04
US20110159076A1 (en) 2011-06-30
CA2650833A1 (en) 2007-12-06

Similar Documents

Publication Publication Date Title
IL250734A0 (en) Transdermal therapeutic system
GB2436010B (en) Therapy device
GB0602178D0 (en) Therapeutic treatment
GB0610680D0 (en) Therapeutic compounds
IL193678A0 (en) Therapeutic compounds
GB0603041D0 (en) Therapeutic compounds
LT2799427T (lt) Terapiniai junginiai
GB0606663D0 (en) Therapeutic compounds
GB0608655D0 (en) Therapeutic Treatment
GB0615809D0 (en) Therapeutic compounds
GB0612971D0 (en) Therapeutic compounds
ZA200809004B (en) Autodestructive transdermal therapeutic system
GB0610909D0 (en) Therapeutic treatment
GB0625349D0 (en) Therapeutic compounds
EP2079704A4 (en) THERAPEUTIC COMPOUNDS
GB0625345D0 (en) Therapeutic compounds
GB0605573D0 (en) Therapeutic Compounds
GB0603455D0 (en) Therapeutic compounds
GB0607153D0 (en) Therapeutic Method
GB0608269D0 (en) Therapeutic compounds
GB0722015D0 (en) Transdermal therapy
GB2439923B (en) Therapeutic compounds
GB0610376D0 (en) Therapeutic treatment
GB0622285D0 (en) Transdermal therapy
GB0607158D0 (en) Therapy